Regulation of the BBB during viral encephalitis: Roles of IL-12 and NOS

Nitric Oxide - Biology and Chemistry

Volumn 3, Issue 4, 1999, Pages 327-339

  Komatsu, Takashi ^a   Ireland, Derek D C ^a   Chung, Nancy ^a   Doré, Anthony ^a   Yoder, Monroe ^a   Shoshkes Reiss, Carol ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

Acquired immunity; Blood brain barrier; Encephalitis; Innate immunity; Interleukin 12; Nitric oxide synthase

Indexed keywords

INTERLEUKIN 12; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CAPILLARY PERMEABILITY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPENDYMA CELL; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VIRUS ENCEPHALITIS;

ANIMALIA; VESICULAR STOMATITIS VIRUS;

EID: 0032841308     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1999.0237     Document Type: Article

References (67)

1. Dawson T. M., Dawson V. L. Nitric oxide: Actions and pathological roles. Neuroscientist. 1:1994;9-20.
2. Zhuo M., Small S. A., Kandel E. R., Hawkins R. D. Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. Science. 260:1993;1946-1950.
3. Peunova N., Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature. 375:1995;68-73.
4. Montague P. R., Gancayco C. D., Winn M. J., Marchase R. B., Friedlander M. J. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science. 263:1994;973-977.
5. Janigro D., West G. A., Nguyen T. S., Winn H. R. Regulation of blood-brain barrier endothelial cells by nitric oxide. Circ. Res. 75:1994;528-538.
6. Boje K. M. K. Inhibition of nitric oxide synthesis partially attenuates alterations in the blood-cerebrospinal fluid barrier during experimental meningitis in the rat. Eur. J. Pharmacol. 272:1995b;297-300.
7. Johnson A. W., Land J. M., Thompson E. J., Bolanos J. P., Clark J. B., Heales S. J. R. Evidence for increased nitric oxide production in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 58:1995.
8. Koedel U., Bernatowicz A., Paul R., Frei K., Fontana A., Pfister H. W. Experimental pneumococcal meningitis: Cerebrovascular alterations, brain edema and meningeal inflammation are linked to the production of nitric oxide. Ann. Neurol. 37:1995;313-323.
9. MacMicking J. D., Willenborg D. O., Wedemann M. J., Rockett K. A., Cowden W. B. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune enephalomyelitis: Enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176:1992;303-307.
10. Mayhan W. G. Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. Brain Res. 686:1995;99-103.
11. Nowicki J. P., Duval D., Poignet H., Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmacol. 204:1991;339-340.
12. Prado R., Watson B. D., Kuluz J., Dietrich W. D. Endothelium-derived nitric oxide synthase inhibtion: Effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats. Stroke. 23:1992;1118-1124.
13. Boje K. M., Arora P. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
14. Kilbourn R. G., Belloni P. Endothelial cell production of nitrogen oxides in response to interferon-γ in combination with tumor necrosis factor, interleukin-1 or endotoxin. J. Natl. Cancer Inst. 82:1990;772-776.
15. Skaper S. D., Facci L., Leon A. Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J. Neurochem. 64:1995;266-276.
16. Boje K. M. K. Cerebrovascular permeability changes during experimental meningitis in the rat. J. Pharmacol. Exp. Ther. 274:1995a;1199-1203.
17. Boje K. M. K. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res. 720:1996;75-83.
18. Iadecola C., Zhang F., Casey R., Nagayama M., Ross M. E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17:1997;9157-9164.
19. Fenyk M. J. E., Garrison A. E., Brunnert S. R., Weidner J. R., Shen F., Shelton B. A., Mudgett J. S. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:1998;2940-2946.
20. Schoenhaut D. S., Chua A. O., Wolitzky A. G., Guinn P. M., Dwyer C. M., McComas W., Familletti P. C., Gately M. K., Gubler U. Cloning and expression of murine IL-12. J. Immunol. 148:1992;3433-3440.
21. Wolf S. F., Temple P. A., Kobayashi M., Young D., Dicig M., Lowe L., Dizialo R., Fritz L., Ferenz C., Hewick R. M., Kelleher K., Herrmann S. H., Clark S. C., Azzoni L., Chan S. H., Trincheiri G., Perussia B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J. Exp. Med. 146:1991;3074-3081.
22. Chan S. H., Perussia B., Gupta J. W., Kobayashi M., Pospisil M., Young H. A., Wolf S., Young D., Clark S. C., Trinchieri G. Induction of interferon-γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:1991;869-879.
23. Chehimi A., Valiante N., D'Andrea A., Rengaraju M., Rosado Z., Kobayashi M., Perussia B., Wolf S. F., Starr S. E., G. Trinchieri G. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur. J. Immunol. 23:1993;1826-1830.
24. Kobayashi M., Fitz L., Ryan M., Hewick R. M., Clark S. C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:1989;827-846.
25. Orange J. S., Salazar-Mather T. P., Opal S. M., Spencer R. L., Miller A. H., McEwen B. S., Biron C. A. Mechanism of interleukin-12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:1995;901-914.
26. Orange J. S., Wolf S. F., Biron C. A. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1994;1253-1264.
27. Komatsu T., Barna M., Reiss C. S. IL-12 promotes recovery from viral encephalitis. Viral Immunol. 10:1997;35-47.
28. Hsieh C. S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of Th1 CD4 T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:1993;547-549.
29. Manetti R., Parronchi P., Giudizi M. G., Piccinni M. P., Maggi E., Trinchieri G., Romagnani S. Natural killer stimulatory factor (interleukin 12) induces T helper type-1 (Th1)-specific immune responses and inhibits the development of IL-4-producing cells. J. Exp. Med. 177:1993;1199-1204.
30. Wolf S. F., Sieburth D., Sypek J. Interleukin-12: A key modulator of immune functions. Stem Cell. 12:1994;154-168.
31. Constantinescu C. S., Frei K., Malipiero U., Rostami A., Fontana A. Astrocytes and microglial produce IL-12. Ann. NY Acad. Sci. 795:1996;323-333.
32. Stalder A. K., Pagenstecher A., Yu N. C., Kincaid C., Chiang C. S., Hobbs M. V., Bloom F. E., Campbell I. L. Lipopolysaccharide-induced IL-12 expression in the central nervous system. And cultured astrocytes and microglia. J. Immunol. 159:1997;1344-1351.
33. Huneycutt B. S., Bi Z., Aoki C. J., Reiss C. S. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J. Virol. 67:1993;6698-6706.
34. Huang P. L., Dawson T. M., Bredt D. S., Snyder S. H., Fishman M. C. Targeted Disruption of the Neuronal Nitric Oxide Synthase Gene. Cell. 75:1993;1273-1286.
35. Bi Z., Reiss C. S. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:1995;2208-2213.
36. Bi Z., Barna M., Komatsu T., Reiss C. S. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J. Virol. 69:1995;6466-6471.
37. Chaturvedi U. C., Dhawan R., Khanna M., Mathur A. Breakdown of the blood-brain barrier during dengue virus infection of mice. J. Gen. Virol. 72:1991;859-866.
38. Doherty P. C., Zinkernagel R. M., Ramshaw I. A. Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis. J. Immunol. 112:1974;1548-1552.
39. Kandel, E, Schwartz, J, and, Jessell, J. 1991, Principles of Neural Science, Elsevier Science, New York.
40. Komatsu T., Ireland D. D. C., Chen N., Reiss C. S. Neuronal expression of NOS-1 is required for host recovery from viral encephalitis. Virology. 1999.
41. Pfister H. W., Fontana A., Tauber M. G., Tomasz A., Scheld W. M. Mechanisms of brain injury in bacterial meningitis: Workshop summary. Clin. Infect. Dis. 19:1994;463-479.
42. Tunkel A. R., Scheld W. M. Pathogenesis and pathophsyiology of bacterial meningitis. Annu. Rev. Med. 44:1993;103-120.
43. Goldblum S. E., Sun W. L. Tumor necrosis factor-α augments pulmonary arterial transendothelial albumin flux in vitro. Am. J. Physiol. 258:1990;L57-L67.
44. Pfister H. W., Bernatowicz A., Kodel U., Wick M. Nitric oxide production in bacterial meningitis. Neurol. Neurosurg. Psychiat. 58:1995;384-385.
45. Tracey K. J., Lowry S. F. The role of cytokine mediators in septic shock. Adv. Surg. 23:1990;21-56.
46. Nag S. Protective effect of flunarizine on blood-brain barrier permeability alterations in acutely hypertensive rats. Stroke. 22:1991;I107-I112.
47. Sakaki T., Tsunoda S., Morimoto T. The influence of the calcium antagonist nimodipine and induced hypertension on the behavior of the cerebral pial arteries, the blood-brain barrier, cerebral edema, and cerebral infarction in cats with one-hour occlusion of the middle cerebral artery. Neurosurgery. 28:1991;267-272.
48. Komatsu T., Bi Z., Reiss C. S. IFN-γ Induced Type I Nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunology. 68:1996;101-108.
49. DeVries H. E., Hoogendoorn K. H., Van Dijk J., Zijlstra F. J., Breimer D. D., Van Berkel Th. J. C., De Boer A. G., Van Dam A.-M., Kuiper J. Eicosanoid production by rat cerebral endothelial cells in vitro: Stimulation by lipopolysaccharide, interleukin-1 and interleukin-6. J. Neuroimmunol. 59:1995;1-8.
50. DeVries H. E., Blom-Roosemalen M. C. M., Oosten M. V., De Boer A. G., Van Berkel T. J. C., Breimer D. D., Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64:1996;37-43.
51. Chen, N. and, Reiss, C. S. 1999, Role of cyclooxygenase-2 in regulation of the blood-brain barrier during viral encephalitis. In preparation.
52. Barna M., Komatsu T., Reiss C. S. Activation of type III nitric oxide synthase in astrocytes following neurotropic viral infection. Virology. 223:1996;331-343.
53. Durieu-Trautmann O., Federici C., Creminon C., Foignant-Chaverot N., Roux F., Claire M., Strosberg A. D., Couraud P. O. Nitric oxide and endothelin secretion by brain microvessel endothelial cells: Regulation by cyclic nucleotides. J. Cell. Physiol. 1993.
54. Gross S. S., Jaffe E. A., Levi R., Kilbourn R. G. Cytokine activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin dependent, calmodulin independent and inhibited by arginine analogs with rank order of potency characteristic of activated macrophages. Biochem. Biophys. Res. Commun. 178:1991;823-829.
55. Buster B. L., Weintrob A. C., Townsend G. C., Scheld W. M. Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect. Immun. 63:1995;3835-3839.
56. Chi O. Z., Wei H. M., Sinha A. K., Weiss H. R. Effects of inhibition of nitric oxide on blood-brain barrier transport in focal cerebral ischemia. Pharmacology. 48:1994;367-373.
57. Hurst R. D., Fritz I. B. Nitric oxide induced perturbations in a cell culture model of the blood-brain barrier. J. Cell. Physiol. 167:1996;89-94.
58. Thompson A. J., Miller D., Youl B., MacManus D., Moore S., Kingsley D., Kendall B., Feinstein A., McDonald W. I. Serial gadolinium enhanced MRI in relapsing/remitting multiple sclerosis. Neurology. 42:1992;60-63.
59. Bo L., Dawson T. M., Wesselingh S., Mork S., Choi S., Kong P. A., Hanley D., Trapp B. D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis. Ann. Neurol. 36:1994;778-786.
60. Pfister H. W., Frei K., Ottnad B., Koedel U., Tomasz T., Fontana A. Transforming growth factor β2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor α-independent early phase of experimental pneumococcal meningitis. J. Exp. Med. 176:1992;265-268.
61. Vodovotz Y., Bogdan C., Paik J., Xie Q. W., Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β J. Exp. Med. 178:1993;605-613.
62. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
63. Radi R., Beckman J. S., Bush K. M., Freeman B. A. Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266:1991;4244-4250.
64. Brown G. C. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett. 369:1995;136-139.
65. Staddon J. M., Herrenknecht K., Smales C., Rubin L. L. Evidence that tyrosine phosphorylation may increase tight junction permeability. J. Cell. Sci. 108:1995;609-619.
66. Plateel M., Dehouck M.-P., Torpier G., Cecchelli R., Teissier E. Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer. J. Neurochem. 65:1995;2138-2145.
67. Watanabe H., Kuhne W., Spahr R., Schwartz P., Piper H. M. Macromolecule permeability of coronary and aortic endothelial monolayers under energy depletion. Am. J. Physiol. 260:1991;H1344-H1352.